Marc Vimolratana

1.1k total citations
23 papers, 452 citations indexed

About

Marc Vimolratana is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Organic Chemistry. According to data from OpenAlex, Marc Vimolratana has authored 23 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 8 papers in Surgery and 4 papers in Organic Chemistry. Recurrent topics in Marc Vimolratana's work include Lung Cancer Diagnosis and Treatment (11 papers), Lung Cancer Treatments and Mutations (7 papers) and Esophageal Cancer Research and Treatment (6 papers). Marc Vimolratana is often cited by papers focused on Lung Cancer Diagnosis and Treatment (11 papers), Lung Cancer Treatments and Mutations (7 papers) and Esophageal Cancer Research and Treatment (6 papers). Marc Vimolratana collaborates with scholars based in United States and United Kingdom. Marc Vimolratana's co-authors include Sean P. Brown, Paul J. Dransfield, Gayathri Swaminath, Jane Zhang, Jian Luo, Daniel C.-H. Lin, Jonathan B. Houze, Masakazu Nakadai, Qingyi Li and Patrick G. Harran and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Molecular Pharmacology.

In The Last Decade

Marc Vimolratana

19 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Vimolratana United States 8 241 184 163 141 66 23 452
Kazunobu Kira Japan 12 184 0.8× 164 0.9× 79 0.5× 221 1.6× 42 0.6× 18 478
Yasuhiro Yonetoku Japan 12 200 0.8× 139 0.8× 80 0.5× 200 1.4× 67 1.0× 20 491
Tomoyuki Odani Japan 11 347 1.4× 215 1.2× 162 1.0× 90 0.6× 95 1.4× 14 542
Guiqing Liang United States 11 171 0.7× 122 0.7× 52 0.3× 104 0.7× 38 0.6× 21 484
Paul J. Dransfield United States 12 331 1.4× 211 1.1× 162 1.0× 244 1.7× 75 1.1× 13 573
Eiji Kawanishi Japan 13 285 1.2× 221 1.2× 131 0.8× 311 2.2× 16 0.2× 20 664
Shuji Kitamura Japan 12 276 1.1× 114 0.6× 76 0.5× 204 1.4× 35 0.5× 14 476
M. F. Sammons United States 9 106 0.4× 80 0.4× 46 0.3× 182 1.3× 17 0.3× 18 321
Changyou Zhou United States 15 300 1.2× 107 0.6× 98 0.6× 179 1.3× 49 0.7× 25 505
Stefanie Keil Germany 9 322 1.3× 159 0.9× 75 0.5× 157 1.1× 29 0.4× 11 477

Countries citing papers authored by Marc Vimolratana

Since Specialization
Citations

This map shows the geographic impact of Marc Vimolratana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Vimolratana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Vimolratana more than expected).

Fields of papers citing papers by Marc Vimolratana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Vimolratana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Vimolratana. The network helps show where Marc Vimolratana may publish in the future.

Co-authorship network of co-authors of Marc Vimolratana

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Vimolratana. A scholar is included among the top collaborators of Marc Vimolratana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Vimolratana. Marc Vimolratana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodríguez-Quintero, Jorge Humberto, et al.. (2024). Minimally invasive surgery for clinical T4 non-small-cell lung cancer: national trends and outcomes. European Journal of Cardio-Thoracic Surgery. 65(3). 2 indexed citations
2.
Rodríguez-Quintero, Jorge Humberto, et al.. (2024). Trends and Disparities in Robotic Surgery Utilization for Non–Small Cell Lung Cancer. Journal of Surgical Research. 302. 24–32. 1 indexed citations
3.
Rodríguez-Quintero, Jorge Humberto, Mohamed Kamel, Marc Vimolratana, et al.. (2024). Surgery for Patients With cT3/4N2M0, Stage IIIB NSCLC. Is It Time to Redefine Resectability?. JTO Clinical and Research Reports. 6(1). 100766–100766.
4.
Rodríguez-Quintero, Jorge Humberto, et al.. (2024). Do socioeconomic factors impair uptake of neoadjuvant therapy for patients with locoregional oesophageal cancer?. European Journal of Cardio-Thoracic Surgery. 67(1).
5.
Rodríguez-Quintero, Jorge Humberto, et al.. (2024). Resection of the Primary Tumor and Survival in Patients with Single-Site Synchronous Oligometastatic Non–Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Database. Journal of the American College of Surgeons. 238(6). 1122–1136. 1 indexed citations
6.
Friedmann, Patricia, et al.. (2024). The Representation of Women Moderators at The Society of Thoracic Surgeons Annual Meeting. The Annals of Thoracic Surgery. 119(1). 227–234. 1 indexed citations
7.
Rodríguez-Quintero, Jorge Humberto, et al.. (2024). Pneumonectomy for non–small cell lung cancer. A National Cancer Database analysis of geographic and temporal trends, outcomes, and associated factors. Surgery. 176(3). 918–926. 1 indexed citations
8.
Rodríguez-Quintero, Jorge Humberto, et al.. (2024). High barriers to treatment are associated with stereotactic radiation instead of surgery for patients with operable stage I non-small cell lung cancer. European Journal of Cardio-Thoracic Surgery. 67(1).
9.
Rodríguez-Quintero, Jorge Humberto, et al.. (2023). Underutilization of Systemic Therapy in Patients With NSCLC Undergoing Pneumonectomy: A Missed Opportunity for Survival. JTO Clinical and Research Reports. 4(8). 100547–100547. 7 indexed citations
10.
Rodríguez-Quintero, Jorge Humberto, et al.. (2023). The Effect of Neoadjuvant Therapy on Esophagectomy for cT2N0M0 Esophageal Adenocarcinoma. Annals of Surgical Oncology. 31(1). 228–238. 3 indexed citations
11.
Rodríguez-Quintero, Jorge Humberto, et al.. (2023). PP.28 Underutilization of Systemic Therapy in Patients Undergoing Pneumonectomy: A Missed Opportunity for Survival. Journal of Thoracic Oncology. 18(3). S19–S20. 2 indexed citations
12.
Kamel, Mohamed, et al.. (2023). Association of socioeconomic factors with the receipt of neoadjuvant therapy for patients with non–small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 167(4). 1458–1466.e4. 3 indexed citations
13.
Rodríguez-Quintero, Jorge Humberto, et al.. (2023). ASO Visual Abstract: The Effect of Neoadjuvant Therapy on Esophagectomy for cT2N0M0 Esophageal Adenocarcinoma. Annals of Surgical Oncology. 31(3). 1595–1596.
14.
Rodríguez-Quintero, Jorge Humberto, Mohamed Kamel, Patricia Friedmann, et al.. (2023). Is underutilization of adjuvant therapy in resected non-small-cell lung cancer associated with socioeconomic disparities?. European Journal of Cardio-Thoracic Surgery. 64(6). 2 indexed citations
15.
Brown, Sean P., Paul J. Dransfield, Marc Vimolratana, et al.. (2018). Discovery of AM-6226: A Potent and Orally Bioavailable GPR40 Full Agonist That Displays Efficacy in Nonhuman Primates. ACS Medicinal Chemistry Letters. 9(7). 757–760. 12 indexed citations
16.
Luo, Jian, Gayathri Swaminath, Sean P. Brown, et al.. (2012). A Potent Class of GPR40 Full Agonists Engages the EnteroInsular Axis to Promote Glucose Control in Rodents. PLoS ONE. 7(10). e46300–e46300. 114 indexed citations
17.
Lin, Daniel C.-H., Qi Guo, Jian Luo, et al.. (2012). Identification and Pharmacological Characterization of Multiple Allosteric Binding Sites on the Free Fatty Acid 1 Receptor. Molecular Pharmacology. 82(5). 843–859. 100 indexed citations
18.
Brown, Sean P., Paul J. Dransfield, Marc Vimolratana, et al.. (2012). Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist. ACS Medicinal Chemistry Letters. 3(9). 726–730. 68 indexed citations
19.
Vimolratana, Marc, et al.. (2010). Palladium-catalyzed amidation of 2-chloropyrimidines. Tetrahedron Letters. 52(9). 1020–1022. 12 indexed citations
20.
Nakadai, Masakazu, et al.. (2004). Spirocycloisomerization of Tethered Alkylidene Glycocyamidines: Synthesis of a Base Template Common to the Palau'amine Family of Alkaloids. Angewandte Chemie International Edition. 44(5). 765–769. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazunobu Kira Breakdown of academic impact, for papers by Yasuhiro Yonetoku Breakdown of academic impact, for papers by Tomoyuki Odani Breakdown of academic impact, for papers by Guiqing Liang Breakdown of academic impact, for papers by Paul J. Dransfield Breakdown of academic impact, for papers by Eiji Kawanishi Breakdown of academic impact, for papers by Shuji Kitamura Breakdown of academic impact, for papers by M. F. Sammons Breakdown of academic impact, for papers by Changyou Zhou Breakdown of academic impact, for papers by Stefanie Keil
Rankless by CCL
2026